Get a Free Quote

Our representative will contact you soon.
Email
Name
Company Name
Message
0/1000
myo inositol and d chiro inositol 401 powder-0

Dietary Supplements

Home >  Products >  Dietary Supplements

Myo-Inositol and D-Chiro-Inositol 40:1 Powder

Myo-Inositol and D-Chiro-Inositol 40:1 Powder is a dual-ingredient inositol formulation concept developed for brands seeking a clearly defined ingredient ratio and flexible powder supplement formats. The proposed formula contains 2,000 mg of myo-inositol and 50 mg of D-chiro-inositol per serving, providing a 40:1 ratio by weight.

Designed for women's nutritional supplement product development, this concept can be evaluated for unflavored or flavored powder formats, with optional folate subject to formula review. Rainwood supports formula customization and private-label packaging development according to project specifications and manufacturing feasibility.

Brand:
Rainwood Biotech
Parameter Proposed Specification
Product Name Myo-Inositol and D-Chiro-Inositol 40:1 Powder
Product Category Women's Nutritional Supplements
Dosage Form Powder; Sachet or Jar Format Under Evaluation
Myo-Inositol 2,000 mg per serving
D-Chiro-Inositol 50 mg per serving
Ingredient Ratio 40:1 by weight
Combined Active Ingredient Weight 2,050 mg per serving
Optional Ingredient Folate, subject to confirmation
Flavor Development Options Unflavored, Lemon, and Red Date
Proposed Packaging 30 Single-Serve Sachets per Box or Sealed Jar Format
Serving Configuration 30 Servings per Pack; Daily Serving Instructions to Be Confirmed
Customization Formula Customization and Private-Label Packaging
  • Product Description
  • Key Product Features
  • Applications
  • Technical Specifications and Quality Control
  • Packaging and Customization
  • Frequently Asked Questions
  • Inquiry
Product Description

Myo-inositol and D-chiro-inositol are two distinct inositol forms used in nutritional supplement formulations. A 40:1 combination provides a defined ratio between the two ingredients and offers brands a clear starting point for developing an inositol-based powder supplement.

The proposed formula uses 2,000 mg of myo-inositol and 50 mg of D-chiro-inositol per serving. The combined active ingredient weight is 2,050 mg, excluding any optional folate, flavoring agents, sweeteners, carriers, or other excipients.

For B2B product development, key considerations include ingredient identity, assay, blend uniformity, serving-size accuracy, powder flow, moisture control, sensory performance, and consistency between the product specification and finished-product label.

img-mv8wbqie-12f17797.png

Key Product Features

Defined 40:1 Ingredient Ratio

The proposed formula establishes a clear 40:1 weight ratio between myo-inositol and D-chiro-inositol, with each ingredient specified separately per serving.

Transparent Serving-Size Design

Separate ingredient declarations help brands align formula calculations, serving instructions, packaging quantities, and finished-product labeling.

Flexible Powder Format

The formulation can be evaluated for single-serve sachets or jar packaging, depending on the intended product configuration and manufacturing feasibility.

Flavor Development Options

Unflavored, lemon, and red-date profiles are proposed for evaluation. Final flavor selection should be based on sensory testing and target-market preferences.

Optional Folate Development

Folate may be considered as an additional ingredient, subject to confirmation of its form, amount, compatibility, and labeling requirements.

B2B Customization Support

Rainwood supports formula customization and private-label packaging development according to confirmed project requirements.

Applications

Potential applications include:

  • Myo-inositol and D-chiro-inositol powder supplements

  • 40:1 ratio inositol formulations

  • Women's nutritional supplement product lines

  • Single-serve powder sachets and jar-based powder products

  • Customizable inositol formulations with optional folate

Final product positioning and labeling should reflect the actual formula, substantiated evidence, and applicable target-market requirements.

Technical Specifications and Quality Control

The following parameters should be established before the commercial specification is finalized:

  • Myo-inositol and D-chiro-inositol identity and assay

  • Verified amount of each ingredient per serving

  • Blend uniformity and serving-size consistency

  • Folate form and amount, if included

  • Total finished-product net weight and excipient composition

  • Powder flow, moisture content, and packaging compatibility

  • Applicable heavy-metal and microbiological limits

  • Appropriate analytical methods and batch-specific COA

  • Packaging integrity and shelf-life validation

Acceptance criteria and testing methods should be confirmed with the manufacturer and aligned with the final product specification.

Packaging and Customization

The proposed retail configuration is 30 servings per pack, with single-serve sachets or a sealed jar under consideration. The final packaging format should be selected according to serving size, formula characteristics, target-market preferences, and packaging feasibility.

If the recommended daily intake is two servings, a 30-serving pack provides 15 days of supply. A 30-day supply at two servings per day would require 60 servings. Packaging quantities and directions for use must remain consistent across the product page, retail label, and packaging artwork.

img-mv8wb43a-06ee9597.png

Frequently Asked Questions

Q1. What is the proposed 40:1 ratio?

The preliminary formula contains 2,000 mg of myo-inositol and 50 mg of D-chiro-inositol per serving, equivalent to a 40:1 weight ratio.

Q2. Does the 2,050 mg figure represent the total powder weight?

No. The 2,050 mg figure represents the combined weight of the two proposed active ingredients. The final powder weight may be higher if folate, flavoring agents, sweeteners, carriers, or other excipients are added.

Q3. Can folate be included in the formula?

Folate is an optional development direction. Its inclusion, chemical form, amount, compatibility, and labeling details must be confirmed before the formula is finalized.

Q4. Which flavor options are available?

Unflavored, lemon, and red-date profiles are proposed for evaluation. Final availability depends on formulation trials and sensory approval.

Q5. Can the product be supplied in sachets or jars?

Both formats are under consideration in the preliminary product brief. Final packaging availability, material specifications, minimum order quantity, and lead time require project-specific confirmation.

Q6. What should brands verify before launching the product?

Brands should confirm ingredient identity, assay, the 40:1 ratio, serving size, finished-product net weight, optional ingredients, quality documentation, packaging configuration, and target-market labeling requirements.

Q7. Can Rainwood support private-label product development?

Rainwood supports formula customization and private-label packaging development, subject to confirmed project requirements and manufacturing feasibility.

GET IN TOUCH

Get a Free Quote

Our representative will contact you soon.
Email
Name
Company Name
Message
0/1000

Get a Free Quote

Our representative will contact you soon.
Email
Name
Company Name
Message
0/1000